Mesenchymal Stem Cells With Pharmacological Combinations Necessary to Maximize Retinal Photoreceptor, Outer and Inner Nuclear Layers Rescue
Cell Biology International · 2026
DOI: 10.1002/cbin.70106 ↗At a glance
Journal article in Cell Biology International, 2026. Written by Girish K Srivastava and 1 co-authors. Institution: Departamento de Cirugía, Oftalmología, Otorrinolaringología y Fisioterapia, Universidad de Valladolid, Valladolid, Spain. Major MEDLINE topics: Mesenchymal Stem Cells, Photoreceptor Cells, Vertebrate. 32 references. Funded by: This study was supported by a regional grant (JCYL BIO/39/VA26/10), a national grant (PS09/00938), and the Centro en Red de Medicina Regenerativa y Terapia Cel….
Abstract (original language)
The rising prevalence of retinal diseases underscores the need for personalized neuroprotection strategies. Mesenchymal stem cells (MSCs) exhibit paracrine neuroprotective potential and are used clinically when transplantation is unnecessary. This study evaluated MSC‐mediated photoreceptor rescue and its enhancement using clinically relevant drugs; nicotinamide (NIC), vasoactive intestinal peptide (VIP), retinoic acid (ATRA), or their combination. Optimizing and personalizing treatments in accordance to retinal damage severity maximizes photoreceptor rescue, offering a targeted approach to retinal disease management. Adipose‐derived MSCs were cocultured with spontaneously degenerating neuroretina explants for 6 days. VIP (5 µM), NIC (10 mM), and ATRA (5 µM) were applied individually and in combination. Photoreceptor recovery and structural changes in the inner limiting membrane (ILM), outer nuclear layer (ONL), and inner nuclear layer (INL) were assessed using Toluidine, Rhodopsin immunofluorescence, and DAPI staining. MSCs alone improved photoreceptor, ILM, ONL, and INL recovery compared to the control. However, combining VIP, NIC, and ATRA led to greater improvement, with NIC being the most effective single treatment. The combination of VIP and NIC preserved retinal structure better than VIP, NIC, and ATRA together, although none fully restored the original structure. Personalized treatment approaches, combining MSCs with specific drugs, can significantly enhance retinal neuroprotection tailored to the degree of damage, emphasizing the need for individualized strategies in retinal disease management.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Departamento de Cirugía, Oftalmología, Otorrinolaringología y Fisioterapia, Universidad de Valladolid, Valladolid, Spain.
- Instituto Universitario de Oftalmobiología Aplicada (IOBA), Universidad de Valladolid, Valladolid, Spain.
ORCID profiles: Girish K Srivastava
Funding
- This study was supported by a regional grant (JCYL BIO/39/VA26/10), a national grant (PS09/00938), and the Centro en Red de Medicina Regenerativa y Terapia Cel…
Cite
APA
Srivastava, G. K., & Singh, A. K. (2026). Mesenchymal Stem Cells With Pharmacological Combinations Necessary to Maximize Retinal Photoreceptor, Outer and Inner Nuclear Layers Rescue. Cell Biology International. https://doi.org/10.1002/cbin.70106
Vancouver
Srivastava GK, Singh AK. Mesenchymal Stem Cells With Pharmacological Combinations Necessary to Maximize Retinal Photoreceptor, Outer and Inner Nuclear Layers Rescue. Cell Biology International. 2026. doi:10.1002/cbin.70106
BibTeX
@article{Srivastava2026,
author = {Srivastava, Girish K and Singh, Amar K},
title = {Mesenchymal Stem Cells With Pharmacological Combinations Necessary to Maximize Retinal Photoreceptor, Outer and Inner Nuclear Layers Rescue},
journal = {Cell Biology International},
year = {2026},
doi = {10.1002/cbin.70106}
}
EUVIMED